MedTrace Logo

Vitamin D Supplementation to Prevent Vitamin D Deficiency for Children With Epilepsy

NCT03536845 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2021-09-13

No results posted yet for this study

Summary

To determine the maintenance dose of vitamin D supplementation required for children with epilepsy to maintain normal vitamin D level.

Conditions

Interventions

DRUG

Vitamin D 3

oral drops

Sponsors & Collaborators

  • Dallah hospital

    collaborator UNKNOWN

  • King Saud University

    lead OTHER

Principal Investigators

  • Reem Al Khalifah · King Saud University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03536845 on ClinicalTrials.gov